Obagi Medical Products Announces Publication of Study in the July Edition of the Aesthetic Surgery Journal

Obagi Medical Products, Inc. OMPI announced the publication of a study showing that the use of its Condition & Enhance System (also marketed as Nu-Derm), when combined with Botulinum Toxin Type A treatments (BOTOX®), provides greater improvement in overall facial appearance, as well as increased patient satisfaction, vs. BOTOX treatments with